William J. Greenlee

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection<i>in vitro</i>and<i>in vivo</i>

Julie Strizki, Serena Xu, Nicole Wagner et al. · Proceedings of the National Academy of Sciences · 2001 · 300 citations · Full text

Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity

Samuel Chackalamannil, Yuguang Wang, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2008 · 267 citations · Full text

Immunology, Cardiovascular Pharmacology, Pharmacotherapy +21

5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

Theresa M. Williams, Terrence M. Ciccarone, Suzanne C. MacTough et al. · Journal of Medicinal Chemistry · 1993 · 265 citations · Full text

Identification of peptide binding residues in the extracellular domains of the AT1 receptor.

Siv A. Hjorth, Hans Schambye, William J. Greenlee et al. · Journal of Biological Chemistry · 1994 · 170 citations · Full text

At1 Receptor, Protein Function, Signal Transduction +13

Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease

Jack D. Scott, Sarah W. Li, Andrew P. J. Brunskill et al. · Journal of Medicinal Chemistry · 2016 · 161 citations · Full text

Neurochemical Biomarkers, Peptide Science, Enzyme 1 +19